EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Metals in Cancer Research: Beyond Platinum Metallodrugs

Angela Casini iD, Alexander Pöthig

ACS Central Science · 28.02.2024 · 10 (2) · 242-250

DOI: 10.1021/acscentsci.3c01340 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift ACS Central Science, online erschienen am 07.02.2024. Verfasst von Angela Casini und 1 weiteren Autor:innen. Beteiligte Einrichtung: Chair of Medicinal and Bioinorganic Chemistry, Department of Chemistry, School of Natural Sciences, Technical University of Munich, Lichtenbergstraße…. Die Arbeit wurde bisher 161-mal zitiert (Crossref) und nennt 107 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The discovery of the medicinal properties of platinum complexes has fueled the design and synthesis of new anticancer metallodrugs endowed with unique modes of action (MoA). Among the various families of experimental antiproliferative agents, organometallics have emerged as ideal platforms to control the compounds' reactivity and stability in a physiological environment. This is advantageous to efficiently deliver novel prodrug activation strategies, as well as to design metallodrugs acting only via noncovalent interactions with their pharmacological targets. Noteworthy, another justification for the advance of organometallic compounds for therapy stems from their ability to catalyze bioorthogonal reactions in cancer cells. When not yet ideal as drug leads, such compounds can be used as selective chemical tools that benefit from the advantages of catalytic amplification to either label the target of interest (e.g., proteins) or boost the output of biochemical signals. Examples of metallodrugs for the so-called "catalysis in cells" are considered in this Outlook together with other organometallic drug candidates. The selected case studies are discussed in the frame of more general challenges in the field of medicinal inorganic chemistry.

Autor:innen und Institutionen

  • Chair of Medicinal and Bioinorganic Chemistry, Department of Chemistry, School of Natural Sciences, Technical University of Munich, Lichtenbergstraße 4, D-85748 Garching b. München, Germany.
  • Catalysis Research Center & Department of Chemistry, School of Natural Sciences, Technical University of Munich, Ernst-Otto-Fischer Str. 1, D-85748 Garching b. München, Germany.

ORCID-Profile: Angela Casini

Zitieren

APA

Casini, A., & Pöthig, A. (2024). Metals in Cancer Research: Beyond Platinum Metallodrugs. ACS Central Science, 10(2), 242-250. https://doi.org/10.1021/acscentsci.3c01340

Vancouver

Casini A, Pöthig A. Metals in Cancer Research: Beyond Platinum Metallodrugs. ACS Central Science. 2024;10(2):242-250. doi:10.1021/acscentsci.3c01340

BibTeX
@article{Casini2024,
  author = {Casini, Angela and Pöthig, Alexander},
  title = {Metals in Cancer Research: Beyond Platinum Metallodrugs},
  journal = {ACS Central Science},
  year = {2024},
  volume = {10},
  number = {2},
  pages = {242--250},
  doi = {10.1021/acscentsci.3c01340}
}
Kostenlos starten →